Why is Insulet Corp. ?
- The company has been able to generate a Return on Capital Employed (avg) of 11.86% signifying low profitability per unit of total capital (equity and debt)
- NET PROFIT(Q) At USD 93.64 MM has Fallen at -50.35%
- INTEREST(Q) Highest at USD 19.6 MM
- EPS(Q) Lowest at USD 0.32
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 23.36%, its profits have risen by 84.3% ; the PEG ratio of the company is 0.6
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- The stock has generated a return of 23.36% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
How much should you hold?
- Overall Portfolio exposure to Insulet Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Insulet Corp. for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 506.5 MM
Lowest at 20.22 %
Fallen by -2.82% (YoY
Highest at USD 2,404.7 MM
Highest at USD 649.1 MM
Highest at USD 148.9 MM
Highest at 22.94 %
Highest at USD 118.2 MM
At USD 93.64 MM has Fallen at -50.35%
Highest at USD 19.6 MM
Lowest at USD 0.32
Here's what is working for Insulet Corp.
Operating Cash Flows (USD MM)
Pre-Tax Profit (USD MM)
Debt-Equity Ratio
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Cash and Cash Equivalents
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Insulet Corp.
Net Profit (USD MM)
Interest Paid (USD MM)
Interest Paid (USD MM)
EPS (USD)
Non Operating income






